Berlex Climara Pro Triglyceride Effect Is Point Of Difference For HRT Patch
Executive Summary
Berlex Labs can highlight Climara Pro's effect on triglycerides as one point of differentiation in marketing the transdermal hormone therapy product
You may also be interested in...
Wyeth Prempro Gets Dementia Warning; FDA Considering HRT Class Labeling
FDA is considering hormone replacement therapy class labeling that would incorporate data from a WHI sub-study showing twice the rate of dementia in patients taking Wyeth's Prempro estrogen/progestin combo
Hormone Therapy Class Labeling Uses Wyeth Template; Appeals Due By March
Sponsors of hormone replacement therapies have two months to pull together data to justify exemptions to FDA's proposed class labeling incorporating risk information from the Women's Health Initiative
FDA Hormone Therapy Risk Management Options Include Narrower Indication
FDA is considering limiting hormone therapy indications to patients with more severe menopausal symptoms or those at a high risk for osteoporosis, Center for Drug Evaluation & Research Director Janet Woodcock, MD, said Oct. 24